Company news
OpSens Inc news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Opsens Solutions Further Expands Intellectual Property Portfolio with USPTO Grant
June 11, 2019
Opsens Signs Landmark Supplier Agreement - Expands Optical Sensing Technology Impact Within Cardiology Segment
April 30, 2019
Opsens - Q2 2019 Revenues Reach $7.9 M, a 46% Increase
April 11, 2019
Opsens Appoints Alan Milinazzo as Executive Chairman of the Board of Directors
March 4, 2019
Opsens announces credit agreement with CIBC Innovation Banking
February 27, 2019
Opsens - Election results for the Board of directors
January 24, 2019
Opsens - Q1 2019 revenues reach a record high of $9.1 M, a 43% increase
January 14, 2019
Opsens' dPR obtains CE marking to sell in Europe
January 9, 2019
UPDATE - Opsens reports Q4 and FY2018 results
November 28, 2018
Opsens receives Health Canada approval for dPR intended for the diagnosis of coronary stenosis with the heart at rest
November 27, 2018
Opsens - First use of dPR for the diagnosis of coronary stenosis with the heart at rest
November 8, 2018
Opsens - 50,000 patients diagnosed with the OptoWire
November 1, 2018
Opsens to Host Investor Webinar on Thursday, October 4 to Provide Update on Recent Developments
October 3, 2018
Opsens - New product for the diagnosis of coronary stenosis with the heart at rest
September 20, 2018
Opsens Reports Q3 2018 Results - Quarterly Revenues Eclipse $6.4 M
July 12, 2018
Opsens applauds Japanese government new regulation supporting diagnosis, such as FFR, before treatment of coronary stenosis
April 24, 2018
Opsens reports Q2 2018 results - Consolidated product sales up 44%
April 12, 2018
Opsens' technology granted FDA approval in Abiomed's Impella Cardiac Pump®
April 3, 2018
Opsens Reports Results of Shareholders Vote
January 31, 2018
Opsens Announces Election Results for the Board of Directors and the Retirement of Claude Belleville
January 23, 2018
Opsens Reports Q1 2018 Results - Record Quarterly Revenues With Growth in all Geographic Regions
January 15, 2018
Opsens' Japanese partner Zeon medical proceeds with Conversion of US$2 million Debenture
November 27, 2017
Opsens Reports 2017 Results - Consolidated Revenues Up 85% for Fiscal 2017
November 15, 2017
Opsens Gets Technological Award
October 24, 2017
Opsens Presents a Short Film at the International Medical Film Festival - Quebec in Good Health
September 13, 2017
Opsens Reports Q3 2017 Results - Another Record Quarter with Revenues Up 130% to $4.9 Million
June 29, 2017
Opsens - Robin Villeneuve Appointed as Chief Financial Officer
June 7, 2017
Opsens Inc. Presentation Now Available for On-Demand Viewing
May 16, 2017
Opsens to Webcast, Live, at Virtualinvestorconferences.com, May 11 at 1: 30 pm ET
May 8, 2017
Opsens Announces departure of CFO
May 5, 2017
Opsens Reports Q2 2017 Results - Quarterly Consolidated Revenues Up 75% to $4.8 Million
April 19, 2017
Opsens Announces Graduation to TSX
February 28, 2017
Opsens Reports Q1 2017 Results - Focused Execution Leads to Record Quarterly Revenues
January 26, 2017
Opsens Inc. completes a $14.95 million equity financing by way of prospectus
December 8, 2016
Opsens Inc. announces receipt for final short form prospectus
December 1, 2016
Opsens Inc. announces upsize to and provides additional details regarding its proposed equity financing
November 23, 2016
Opsens Announces Equity Financing
November 22, 2016
Opsens Reports Results for 2016 - Record Total Revenues Driven by Tenfold Increase in FFR Sales
November 16, 2016
Opsens receives 510(k) clearance for the OptoMonitor II providing extended indication
September 26, 2016
Opsens announces partnership with Precise Downhole Services in the energy sector
September 22, 2016
Opsens Appoints Pat Mackin to its Board of Directors
September 7, 2016
Circulation Journal highlights OptoWire performance
August 15, 2016
Opsens Announces Fiscal 2016 Third Quarter Results - Sales of $2,125,000, up 156% Year-Over-Year
July 5, 2016
Opsens receives Health Canada approval for the sale of OptoWire II
June 22, 2016
Opsens completes $5 million private placement
May 17, 2016
Opsens announces results for its second quarter 2016
April 19, 2016
Opsens receives FDA 510(k) clearance for the OptoWire II
March 16, 2016
OPSENS named to the 2016 TSX Venture TOP 50®
March 8, 2016
Opsens hires George Quinoy as Vice President / General Manager U.S. Commercial Sales & Operations
January 25, 2016
Opsens reports Q1 2016 results
January 19, 2016
Decks
The 5 newest of 12 decks. Every deck is listed under its year.
- Investor Presentation (November 2023)
Investor deck · 48 slides · Nov 22, 2023
- Investor Presentation (July 2023)
Investor deck · 48 slides · Jul 31, 2023
- Investor Presentation (July 2023)
Investor deck · 44 slides · Jul 31, 2023
- Investor Presentation (May 2023)
Investor deck · 48 slides · May 31, 2023
- Investor Presentation (2023)
Investor deck · 44 slides · Mar 1, 2023